PATENT CLAIM ANALYSIS

Application Number: 15868301
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["544", "296000"]

Abstract:
The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1 , R 2 , R 3 , X 1 , X 2 , A and Cy variable in Formula I-I all have the meaning as defined herein.

Claim (Index 22):
A compound of  claim 1 , wherein Cy is optionally substituted with from 1 to 5 R Cy  substituents selected from the group consisting of F, Cl, Br, I, \u2014OH, \u2014CN, \u2014NO 2 , \u2014SF 5 , C 1-8  alkyl, C 1-8  haloalkyl, C 1-8  heteroalkyl, -(L Cy ) 0-1 -3-8 membered cycloalkyl, -(L Cy ) 0-1 -3-8 membered heterocycloalkyl, -(L Cy ) 0-1 -5 to 6 membered heteroaryl, -(L Cy ) 0-1 -C 6  aryl, wherein L Cy  is selected from the group consisting of \u2014C(O)\u2014, \u2014C(O)CH 2 \u2014, \u2014OCH 2 \u2014, \u2014CH 2 O\u2014, \u2014CH 2 \u2014, \u2014CH 2 CH 2 \u2014, \u2014CH 2 OCH 2 \u2014, \u2014N(H)CH 2 \u2014, \u2014N(C 1-3  alkyl)CH 2 \u2014, CH 2 N(H)\u2014, \u2014CH 2 N(C 1-3  alkyl)-; wherein said 3-8 membered cycloalkyl is selected from the group consisting of propane, butane, pentane and hexane; wherein said 3 to 8 membered heterocycloalkyl is selected from the group consisting of oxetane, tetrahydrofuran, tetrahydropyran, oxepane, azetidine, pyrrolidine, piperidine and azepane; wherein said 5 to 6 membered heteroaryl is selected from the group consisting of pyrrole, pyrazole, imidazole, thiophene, thiazole, oxazole, trizole, pyridine, pyrimidine, pyrazine, pyridazine; wherein said C 6  aryl is phenyl; and wherein R Cy  is optionally substituted with from 1 to 5 R RCy  substitutents selected from, F, Cl, Br, I, \u2014NH 2 , \u2014OH, \u2014CN, \u2014NO 2 , \u2550O, \u2014SF 5 , C 1-4  alkyl, C 1-4  haloalkyl, C 1-4  alkoxy, C 1-4  (halo)alkyl-C(\u2550O)\u2014, C 1-4  (halo)alkyl-S(O) 0-2 \u2014, C 1-4  (halo)alkyl-N(H)S(O) 0-2 \u2014, C 1-4  (halo)alkyl-S(O) 0-2 N(H)\u2014, (halo)alkyl-N(H)\u2014S(O) 0-2 N(H)\u2014, C 1-4  (halo)alkyl-C(\u2550O)N(H)\u2014, C 1-4  (halo)alkyl-N(H)\u2014C(\u2550O)\u2014, ((halo)alkyl) 2 N\u2014C(\u2550O)\u2014, C 1-4  (halo)alkyl-OC(\u2550O)N(H)\u2014, C 1-4  (halo)alkyl-OC(\u2550O)N(H)\u2014, (halo)alkyl-N(H)\u2014C(\u2550O)O\u2014, ((halo)alkyl) 2 N\u2014C(\u2550O)O\u2014, C 1-4  alkylthio, C 1-4  alkylamino and C 1-4  dialkylamino.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.51351
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15041375', '14267011', '14772735', '14772726', '13899469']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8444730772344071
- 35 USC 102 Novelty (BERT): 0.6101297115319255
- Combined Prediction Score: 0.821038740664159
- Mean Citation Score: 462.6317
- Max Citation Score: 543.9999
- Similarity Product: 534.842129619205

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test